Watch MRMD. Know when insiders buy.
One email the day a filing lands. Free.
MRMD
MARIMED INC.
0.07
−0.00 −1.35%
USD · close Sep 18
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
61
WATCH · shorts 61
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $29.4MP/E —DIV YIELD —FCF YIELD 27.22%REV TTM $163.8M +4.4%NET INCOME −$15MNET DEBT $76.1M52W 0.06 – 0.17SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $41.9M | +6.1% | 38.7% | $418K | −$3.6M | — | -0.01 | $2.2M | $298K | $1.9M | Aug 13 |
| Q1 2026 · Mar 31 | $39.5M | +4.2% | 38.7% | $125K | −$3.8M | — | -0.01 | $949K | $373K | $576K | May 14 |
| Q4 2025 · Dec 31derived | $41.6M | +6.9% | 25.2% | −$4.5M | −$4.6M | — | -0.01 | $3.4M | $33K | $3.4M | Mar 12 |
| Q3 2025 · Sep 30 | $40.8M | +0.4% | 40.1% | $1.6M | −$2.9M | — | -0.01 | $2.7M | $559K | $2.1M | Nov 6 |
| Q2 2025 · Jun 30 | $39.5M | −2.3% | 40.3% | $1M | −$1.4M | — | 0.00 | $297K | $309K | −$12K | Aug 13 |
| Q1 2025 · Mar 31 | $37.9M | −0.1% | 39.8% | −$910K | −$5.5M | — | -0.01 | $1.3M | $266K | $1M | May 14 |
| Q4 2024 · Dec 31derived | $38.9M | +0.1% | 32.5% | −$1.5M | −$8.3M | — | -0.02 | −$413K | $1.1M | −$1.5M | Mar 12 |
| Q3 2024 · Sep 30 | $40.6M | +4.6% | 41.3% | $1.3M | −$1M | — | 0.00 | $803K | $2.6M | −$1.8M | Nov 6 |
| Q2 2024 · Jun 30 | $40.4M | — | 41.8% | $956K | −$1.7M | — | 0.00 | $3.2M | $5M | −$1.8M | Aug 7 |
| Q1 2024 · Mar 31 | $37.9M | — | 43.4% | $2M | −$1.3M | — | 0.00 | $3.2M | $3.4M | −$158K | May 8 |
| Q4 2023 · Dec 31derived | $38.9M | — | 44.5% | $2.4M | −$10.2M | — | -0.02 | $3.2M | $5.4M | −$2.1M | Mar 6 |
| Q3 2023 · Sep 30 | $38.8M | — | 43.4% | $3.3M | −$4.3M | — | -0.01 | $7.9M | $6M | $1.9M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $159.8M | 36.2% | −$2.8M | −$14.5M | -9.1% | -0.04 | $7.7M | $1.2M | $6.5M | — | — |
| FY2024 · to Dec 31 | $157.7M | 39.7% | $2.6M | −$12.5M | -7.9% | -0.03 | $6.8M | $12M | −$5.2M | — | — |
| FY2023 · to Dec 31 | $148.6M | 44.4% | $14.4M | −$16M | -10.8% | -0.04 | $7.9M | $20.1M | −$12.2M | — | — |
| FY2022 · to Dec 31 | $134M | 47.7% | $20.4M | $13.5M | 10.0% | 0.04 | $7.3M | $12.1M | −$4.8M | — | — |
| FY2021 · to Dec 31 | $121.5M | 54.6% | $26.9M | $7.2M | 5.9% | 0.02 | $35.9M | $17.9M | $18M | — | — |
| FY2020 · to Dec 31 | $50.9M | 61.5% | $14.5M | $2.1M | 4.2% | 0.01 | $3.4M | $4.7M | −$1.3M | — | — |
Every number comes from MARIMED INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.